Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

Below are the top small-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Hi Tech Pharmacal Co

is 17.45%. Hi Tech Pharmacal's revenue for the same period is $230.00 million. The trailing-twelve-month return on assets at Akorn

is 12.12%. Akorn's PEG ratio is 0.91. The trailing-twelve-month return on assets at Par Pharmaceutical Companies

is 10.74%. Par Pharmaceutical's operating margin for the same period is 18.40%. The trailing-twelve-month return on assets at Medicis Pharmaceutical

is 5.02%. Medicis Pharmaceutical's revenue for the same period is $763.68 million.